Summary
Cerebrospinal fluid 5-hydroxyindoleacetic acid (5HIAA), homovanillic acid (HVA), and tryptophan in both CSF and plasma were measured in a carefully selected group of 33 depressed women. Strict and explicit inclusion and exclusion criteria were used, and CSF was taken under controlled circumstances. Seventeen operationally defined and uniformly rated psychiatric symptoms as well as global depression severity and 12 clinical background variables were correlated with the four biochemical parameters, using multivariate regression analysis based on Spearman's rank correlation coefficient according to the nature of the data.
Global depression severity did not correlate with any of the biochemical variables; there were, however, significant correlations between CSF 5HIAA and anxiety, insomnia, and suicide on the one hand, and between CSF HVA and motor symptoms and paranoidity on the other hand. Background variables showed only a few-and much weaker-correlations. It was concluded that central monoamine metabolism does affect some particular psychiatric symptoms but is not parallel with the complex clinical construct of the depressive disease. Further studies using isolated psychopathological symptoms instead of nosological categories are suggested in clinical neurochemistry.
Similar content being viewed by others
Abbreviations
- Dysthymia:
-
depressed mood, despair, dejection, hopelessness if congruently reflected in subjective experience and behavior
- Anxiety:
-
fear, tension, restlessness, worrying, ‘nervousness’ if accompanied by congruent vegetative signs or stereotypies
- Suicide:
-
intention, planning, preparation or attempt, except if obviously only a provocative statement
- Anhedonia:
-
loss of interest in pleasure-giving and -receiving (including sexual libido), if it has been a painful change of affect
- Insufficiency:
-
feeling of uselessness, inadequacy, with subjective loss of ability to appropriately think, act, and decide
- Fatigability:
-
loss of energy, helplessness, tiredness which demands extra repose which however does not bring about restoration
- Anorexia:
-
only if real weight loss (at least 2.5 kg) is present
- Insomnia:
-
only if total sleep time has been reduced by at least 3 h and it causes important subjective trouble
- Somatization:
-
all subjectively relevant physical complaints that are not readily explained by medical disease
- Obsession-Compulsion:
-
thoughts and acts the patient feels irresistibly compelled to perform while considering them unpleasant and irrational
- Hypochondria:
-
pervasive fear of or presumption about the presence of a severe or life- threatening disease without its actual signs
- Agitation:
-
permanent motor restlessness that interferes with relaxation and orderly activities
- Retardation:
-
reduction and slowing down of voluntary and expressive movements without causative medical or CNS disease
- Perseveration:
-
repetition of the same word, phrase, or topic if hampers reasonable communication and unexplained by aphasia
- Paranoia:
-
uncontrollable feelings of being intentionally wronged, injured, or pursued by real people, if disproportionate to reality or if it motivates acts causing greater disadvantage that that presumably being submitted to
- Depressive thoughts:
-
permanent and not easily controlled feelings about guilt, sin, worthlessness, impoverishment, damnation
- Negation:
-
lack of insight, no acceptance of the possibility of an illness or even of a change when confronted with the present symptoms
References
Asberg M, Thoren P, Traskman L, Bertilsson L, Ringsberger K (1976) “Serotonin depression”, a biochemical subgroup within the affective disorders? Science 191:478–480
Asberg M, Montgomery SA, Perris C, Schalling D, Sedvall G (1978) A comprehensive psychopathological rating scale. Acta Psychiat Scand Suppl 271:5–28
Asberg M, Bertilsson L (1979) Serotonin in depressive illness, studies of CSF 5HIAA. In: Saletu B et al (eds) Neuropsychopharmacology. Pergamon Press, Oxford
Banki CM (1977) Correlation between anxiety and related symptoms with cerebrospinal fluid 5-hydroxyindoleacetic acid in depressed women. J Neur Transmiss 41:135–143
Banki CM, Molnar G (1980) Cerebrospinal fluid 5HIAA as an index of central serotonergic processes. In: Brzin M et al (eds) Synaptic constituents in health and disease. Pergamon Press, Ljubljana Oxford
Baumann U (1976) Methodische Untersuchungen zur Hamilton-Depression-Skala. Arch Psychiat Nervenkr 222:359–375
Berger PA, Faull KF, Kilkowski J (1980) Cerebrospinal fluid monoamine metabolites in depression and schizophrenia. Am J Psychiatry 137:174–180
Bulat M (1980) Dynamics of biochemical compartmentalization of the cerebrospinal fluid system. In: Brzin M et al (eds) Synaptic constituents in health and disease. Pergamon Press, Ljubljana Oxford
Carlsson A, Lindquist M (1978) Dependence of serotonin and catecholamin synthesis on concentration of precursor amino acids in rat brain. Naunyn-Schmiedeberg Arch Pharmacol 303:157–161
d'Elia G, Lehmann J, Raotma H (1979) Bimodal distribution of serum tryptophan level. Acta Psychiat Scand 60:10–16
Denckla WD, Dewey HK (1967) Determination of tryptophan in plasma, liver and urine. J Lab Clin Med 69:160–169
Folstein MF, Folstein SE, McHugh PR (1975) Mini mental state, a practical method for grading the cognitive state of patients for the clinician. J Psychiat Res 12:189–198
Fujiwara J, Otsuki S (1974) Subtypes of affective psychoses classified by response on amine precursors and monoamine metabolites. Fol Psychiat Neurol Jap 28:93–100
Goodwin FK, Post RM, Jimerson D (1975) Studies of CSF amine metabolites in affective illness and schizophrenia. Proc 6th Int Congr Pharmacol, Helsinki
Kemerer VF, Lichtenfeld DM, Koch TR (1979) A column chromtographic method for the determination of serotonin and 5-hydroxyindoleacetic acid in cerebrospinal fluid. Clin Chim Acta 92:81–85
Knorring L von, Perris C, Jacobsson L (1978) A multi-aspect classification of mental disorders. Acta Psychiat Scand 58:401–412
Koehler K, Brüske J, Jacoby C (1978) Kraepelin-oriented research diagnosable schizophrenia, mania and depression in Schneider-negative schizophrenics. Arch Psychiat Nervenkr 225: 315–324
Murphy DL, Costa JL (1975) Utilization of cellular studies of neurotransmitter-related enzymes and transport processes in man for the investigation of biological factors in behavioral disorders. In: Mendels J (ed) The psychobiology of depression. Spectrum Publ, New York
Post RM, Kotin J, Goodwin FK (1973) Psychomotor activity and cerebrospinal fluid amine metabolites in affective illness. Am J Psychiatry 130:67–72
Post RM, Goodwin FK (1975) Studies on CSF amine metabolites in depressive patients, conceptual problems and theoretical implications. In: Mendels J (ed) The psychobiology of depression. Spectrum Publ, New York
van Praag HM, Korf J (1971) Endogenous depression with and without disturbances in the serotonin metabolism: a biochemical classification? Psychopharmacology 19:148–152
van Praag HM, Lakke JPW, Schut T (1975) Dopamine metabolism in depression, psychoses, Parkinson disease: the problem of specificity of biological variables in behavioural disorders. Psychol Med 5:138–146
van Praag HM (1977) Depression and schizophrenia: a contribution on their chemical pathologies. Spectrum Publ, New York
van Praag HM, de Haan S (1979) Central serotonin metabolism and frequency of depression. Psychiat Res 1:219–224
Sváb J (1979) Multivariate methods in biometrics. Mezogazd Kiado, Budapest (in Hungarian)
Vestergaard P, Sörensen T, Hoppe E (1979) Biogenic amine metabolites in cerebrospinal fluid of patients with affective disorders. In: Saletu B et al (eds) Neuropsychopharmacology. Pergamon Press, Oxford
Westerink BHC, Korf J (1975) Determination of nanogram amounts of HVA in the central nervous system with a rapid semiautomated fluorometric method. Biochem Med 12:106–115
Zarifian E, Loo H (1979) General survey of the possible correlation between psychiatric diagnosis and biological modifications. In: Saletu B et al (eds) Neuropsychopharmacology. Pergamon Press, Oxford
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Banki, C.M., Molnar, G. & Fekete, I. Correlation of individual symptoms and other clinical variables with cerebrospinal fluid amine metabolites and tryptophan in depression. Arch. F. Psychiatr. U. Z. Neur. 229, 345–353 (1981). https://doi.org/10.1007/BF01833162
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF01833162